Eligible AACR 2019 Annual Meeting Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 12 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 9 10 11 12 presentations: 1 to 25 of 299
Computationally assessing the origins of tumor aggressivity
Paul C Boutros
UCLA, Los Angeles, CA, United States
from AACR Annual Meeting 2019 on March 31, 2019 7:00 AM-8:00 AM
DNA damage responses: Canonical to noncanonical
Michael B Kastan
Duke Cancer Institute, Durham, NC, United States
from AACR Annual Meeting 2019 on March 31, 2019 7:00 AM-8:00 AM
High-dimensional single-cell mass cytometry in translational cancer research
Kara L. Davis
Stanford Univ., Stanford, CA, United States
from AACR Annual Meeting 2019 on March 31, 2019 7:00 AM-8:00 AM
Where things stand today: A realistic appraisal of boron neutron capture therapy as a cancer treatment modality
Rolf F Barth
Ohio State Univ., Columbus, OH, United States
from AACR Annual Meeting 2019 on March 31, 2019 1:00 PM-2:45 PM
BNCT Physics
Hanna Koivunoro
Neutron Therapeutics and University of Helsinki, Helsinki, Finland
from AACR Annual Meeting 2019 on March 31, 2019 1:00 PM-2:45 PM
BNCT in treatment of head and neck cancer
Leena Kankaanranta
Helsinki Univ. Central Hospital, Helsinki, Finland
from AACR Annual Meeting 2019 on March 31, 2019 1:00 PM-2:45 PM
Experience of BNCT for glioblastoma and current status of accelerator based BNCT
Akira Matsumura
University of Tsukuba, Tsukuba, Japan
from AACR Annual Meeting 2019 on March 31, 2019 1:00 PM-2:45 PM
Targeting master transcription factor dependency in pediatric cancer
Charles Lin
Baylor College of Medicine, Houston, TX, United States
from AACR Annual Meeting 2019 on March 31, 2019 1:00 PM-2:45 PM
Neuroblastoma: A developmental twist
Rogier Versteeg
dept. of Oncogenomics, Amsterdam UMC - Univ. of Amsterdam, Amsterdam, Netherlands
from AACR Annual Meeting 2019 on March 31, 2019 1:00 PM-2:45 PM
Core regulatory circuitries and dependencies in pediatric cancer
Kimberly Stegmaier
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2019 on March 31, 2019 1:00 PM-2:45 PM
Integrating genomics into precision cancer medicine
Elaine R Mardis
Nationwide Children's Hospital, Columbus, OH, United States
from AACR Annual Meeting 2019 on April 1, 2019 7:00 AM-8:00 AM
Targeting ALK in neuroblastoma: From discovery to phase 3 and back to the lab
Yael P Mosse
Children's Hospital of Philadelphia, Philadelphia, PA, United States
from AACR Annual Meeting 2019 on April 1, 2019 7:00 AM-8:00 AM
Chairperson
Sharon Y R Dent
UT MD Anderson Cancer Ctr., Smithville, TX, United States
from AACR Annual Meeting 2019 on April 1, 2019 1:00 PM-2:45 PM
SAGA functions in development and disease
Sharon Y R Dent
UT MD Anderson Cancer Ctr., Smithville, TX, United States
from AACR Annual Meeting 2019 on April 1, 2019 1:00 PM-2:45 PM
Aberrant polycomb repression in midline and hindbrain tumors
Peter W Lewis
University of Wisconsin-Madison, Madison, WI, United States
from AACR Annual Meeting 2019 on April 1, 2019 1:00 PM-2:45 PM
Principles of epigenetics and chromatin in development and human disease
Ali Shilatifard
Northwestern Univ. Feinberg School of Medicine, Chicago, IL, United States
from AACR Annual Meeting 2019 on April 1, 2019 1:00 PM-2:45 PM
Chemical biology-based approach to understanding and overcoming resistance of cancers to therapies
Stuart L Schreiber
Harvard University and Broad Institute, Cambridge, MA, United States
from AACR Annual Meeting 2019 on April 1, 2019 1:00 PM-2:45 PM
Inactivating STK11/LKB1 genomic alterations are a major driver of primary resistance to PD-1 axis blockade in non-squamous non-small cell lung cancer
Ferdinandos Skoulidis
The University of Texas MD Anderson Cancer Center, Houston, TX, United States
from AACR Annual Meeting 2019 on April 1, 2019 1:00 PM-2:45 PM
Strategies to overcome resistance to targeted therapy of lymphoma based on functional genomic and chemical screens
Louis M Staudt
National Cancer Institute, Bethesda, MD, United States
from AACR Annual Meeting 2019 on April 1, 2019 1:00 PM-2:45 PM
Systematic interrogation of cancer dependencies and synthetic lethal interactions
William C Hahn
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2019 on April 1, 2019 1:00 PM-2:45 PM
A chromatin trans-regulatory pathway implicated in cancer and developmental overgrowth
Chao Lu
Columbia University, New York, NY, United States
from AACR Annual Meeting 2019 on April 2, 2019 12:30 PM-1:00 PM
Fusion oncogenes co-opt developmental programs for rhabdomyosarcoma tumorigenesis
Genevieve C. Kendall
UT Southwestern Medical Ctr., Dallas, TX, United States
from AACR Annual Meeting 2019 on April 2, 2019 1:00 PM-3:00 PM
Implications of T cell variance in pediatric immunotherapy
David M Barrett
Children's Hospital of Philadelphia, Philadelphia, PA, United States
from AACR Annual Meeting 2019 on April 2, 2019 1:00 PM-3:00 PM
Initiation of FN-RMS from endothelial progenitors
Catherine J Drummond
University of Otego, Dunedin, New Zealand
from AACR Annual Meeting 2019 on April 2, 2019 1:00 PM-3:00 PM
Discovery and development of GPC2 as an immunotherapeutic target in neuroblastoma and other cancers
Kristopher R Bosse
Children's Hospital of Philadelphia, Philadelphia, PA, United States
from AACR Annual Meeting 2019 on April 2, 2019 1:00 PM-3:00 PM
<< first | < prev page: of 12 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 9 10 11 12 presentations: 1 to 25 of 299